{"view":"<div class=\"w_popup\" id=\"popup_ressources\">\r\n\t<div class=\"overlay\"><\/div> \r\n\t<div data-width=\"500\" data-height=\"350px\" class=\"popup-wrapped\" style=\"width:500px;margin-left:-250px;height:350px;\">\r\n\t\t<div class=\"popup-header\">  \r\n\t\t\t<div>\r\n\t\t\t\tRessources\t\t\t\t<a href=\"\" class=\"popup-close\" data-event=\"w_closePopup\"><i class=\"fa fa-times\"><\/i><\/a>\r\n\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t<div class=\"popup-body\">\r\n\t\t\t<div style=\"padding:20px;\">\r\n\t<h3 style=\"margin:0\">L&rsquo;immunoth\u00e9rapie cellulaire<\/h3>\r\n\t<p>Dr Delisle est clinicien-chercheur \u00e0 l\u2019H\u00f4pital Maisonneuve-Rosemont et professeur agr\u00e9g\u00e9 \u00e0 l\u2019Universit\u00e9 de Montr\u00e9al. Dans cette conf\u00e9rence, il nous parle de l\u2019immunoth\u00e9rapie cellulaire, un des traitements du cancer du sang \u00e0 l\u2019aide de cellules immunitaires \u00ab \u00e9duqu\u00e9es \u00bb au pr\u00e9alable en laboratoire.<\/p>\r\n\t<div class=\"action\">\r\n\t\t\t\t<a class=\"button\" target=\"_blank\" href=\"https:\/\/www.youtube.com\/watch?v=jkzq9rU-Wkw&feature=youtu.be\">Consulter<\/a>\r\n\t\t\r\n\t\t\t<\/div>\r\n<\/div>\t\t<\/div>\r\n\t<\/div> \r\n<\/div>"}